Saturday, October 01, 2016
 
 
Video: Page (1) of 1 - 02/23/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Oncolytics Biotech Completes Enrollment for REOLYSIN Transla

By DMO Affiliate
Oncolytics Biotech (ONCY) today announced the completion of enrollment in its translational clinical trial that investigated REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases (REO 013). The trial's prim
Oncolytics Biotech Completes Enrollment for REOLYSIN Transla




Page: 1


null
 
 
 
 
 
 
Technology

Personal Tech

Internet
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines